Prestige Consumer Healthcare Inc. (NYSE:PBH) Stake Trimmed by Bokf Na

Bokf Na cut its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 12.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 6,133 shares of the company’s stock after selling 856 shares during the period. Bokf Na’s holdings in Prestige Consumer Healthcare were worth $454,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in PBH. Bank of America Corp DE lifted its position in shares of Prestige Consumer Healthcare by 6.4% in the 4th quarter. Bank of America Corp DE now owns 594,098 shares of the company’s stock valued at $46,393,000 after acquiring an additional 35,830 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Prestige Consumer Healthcare by 1,073.3% in the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company’s stock valued at $15,923,000 after purchasing an additional 186,524 shares in the last quarter. Lido Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth $226,000. Northern Trust Corp grew its holdings in shares of Prestige Consumer Healthcare by 10.9% during the fourth quarter. Northern Trust Corp now owns 813,076 shares of the company’s stock valued at $63,493,000 after buying an additional 80,055 shares in the last quarter. Finally, Tudor Investment Corp ET AL acquired a new position in Prestige Consumer Healthcare during the fourth quarter valued at $1,315,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares in the company, valued at $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. StockNews.com lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Friday. Royal Bank of Canada upgraded shares of Prestige Consumer Healthcare to a “hold” rating in a research note on Thursday. DA Davidson boosted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a report on Friday, February 7th. Oppenheimer increased their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday, February 13th. Finally, Canaccord Genuity Group upped their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Hold” and a consensus price target of $93.33.

Prestige Consumer Healthcare Trading Up 0.7 %

Prestige Consumer Healthcare stock opened at $87.65 on Friday. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04. The company’s fifty day moving average price is $83.18 and its two-hundred day moving average price is $81.32. The company has a market capitalization of $4.34 billion, a price-to-earnings ratio of 20.53, a PEG ratio of 2.69 and a beta of 0.44. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The firm had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. During the same period in the previous year, the company earned $1.02 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. On average, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.